Actavis to Offer Generic Epilepsy/bipolar Drug

Source: PharmaManufacturing.com

Jul 16, 2013

NBCNews.com

Actavis Inc. said it has received U.S. approval to sell a generic version of Lamictal, a tablet for treating epilepsy and bipolar disorder. The FDA has given approval for the company to sell lamotrigine tablets in doses of 25, 50, 100 and 200 milligrams. Read the full story
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments